Theralase announces up to C$5M private placement to fund cancer and virus treatment studies
Theralase Technologies Inc. has launched a private placement to raise between C$3 million and C$5 million by issuing units at C$0.24 each, including shares and warrants exercisable until 2031. The funds will support toxicology studies for their cance...
